GTS Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

GTS Securities’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-20,740	Closed	-$2.67M	–	2790
2024 Q3	$2.67M	Sell	20,740 -9,100	-30%	-$1.19M	0.01%	1350
2024 Q2	$3.39M	Buy	29,840 +4,335	+17%	+$464K	0.01%	1120
2024 Q1	$3.39M	Sell	25,505 -13,450	-35%	-$1.76M	0.01%	1118
2023 Q4	$4.75M	Buy	38,955 +27,630	+244%	+$2.11M	0.01%	1040
2023 Q3	$863K	Buy	+11,325	New	+$1.16M	﹤0.01%	2128

Other funds holding LABU

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

EFG

Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GTS Securities's LABU Position: Q2 2026 in Review

GTS Securities opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026: 17,460 shares worth $5.1M. The stake represents 0.11% of the portfolio and ranks #108 among its holdings. This is a return to the name: GTS Securities previously reported a position in LABU as recently as Q4 2025.

GTS Securities first reported a position in LABU in Q2 2023 and has held it in 10 quarters since. The position peaked at $6.09M in Q3 2024. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

GTS Securities held 17,460 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $5.1M as of Q2 2026.
Direxion Daily S&P Biotech Bull 3X ETF was a new GTS Securities position in Q2 2026.
Direxion Daily S&P Biotech Bull 3X ETF made up 0.11% of GTS Securities's portfolio in Q2 2026, its #108 holding.
GTS Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2023 and has held it in 10 quarters since.
GTS Securities's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $6.09M in Q3 2024.
36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.